Glaxosmithkline reported GBP5.51B in Operating Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US USD 10.21B 1.08B
Amgen AMGN:US USD 4.61B 695M
AstraZeneca AZN:LN USD 9.74B 495M
Aurora Cannabis Inc ACB:CN CAD 103.76M 571.03M
Bristol Myers Squibb BMY:US USD 9.46B 716M
Canopy Growth Corp WEED:CN CAD 277.53M 1.69B
Corcept Therapeutics CORT:US USD 69.79M 2.16M
Drreddys Laboratories RDY:US INR 51.28B 4.35B
Eli Lilly And LLY:US USD 5.47B 200.3M
Endo International Ordinary Shares ENDP:US USD 1.18B 1.13B
GlaxoSmithKline GSK:LN GBP 5.51B 1.13B
Glaxosmithkline GSK:US GBP 5.51B 1.13B
Horizon Pharma HZNP:US USD 764.75M 23.1M
Johnson & Johnson JNJ:US USD 19.51B 1.54B
Merk MRK:US USD 10.32B 624M
Novartis NOVN:VX USD 11.05B 378M
Pacira Pharmaceuticals PCRX:US USD 146.18M 8M
Perrigo Ordinary Shares PRGO:US USD 1.07B 71.2M
Pfizer PFE:US USD 19.12B 5.9B
Phibro Animal Health PAHC:US USD 218.84M 13.54M
Prestige Brands PBH:US USD 188.34M 16.55M
Roche Holding ROG:VX 20.75B 3.26B
Supernus Pharmaceuticals SUPN:US USD 178.88M 20.17M
Takeda 4502:JP JPY 949.56B 51.69B
Teva Pharmaceutical TEVA:IT USD 3.18B 1.56B
Valeant Pharmaceuticals VRX:CN USD 1.23B 461M
Zoetis ZTS:US USD 1.34B 47M